FDA warns Global Cosmetics over manufacturing quality failures in OTC hand sanitizer, including no methanol testing of ethanol.
What happened
FDA reviewed records the company submitted after a September 12, 2022 request for records. It found the company did not adequately test incoming ingredients, including testing ethanol for methanol; lacked adequate stability data; and its quality-control unit did not effectively oversee manufacturing. FDA placed the firm on Import Alert 66-40 on February 16, 2024.
What FDA found
The company did not show that it tests each incoming ingredient for identity, including testing ethanol for methanol.
21 CFR 211.84(d)(1)The company lacked adequate stability testing to support storage conditions and expiration dates for its hand sanitizer.
21 CFR 211.166(a)The company's quality-control unit did not effectively approve or reject materials and products or oversee quality.
21 CFR 211.22(a)
What FDA wants
FDA asks the company to respond in writing within 15 working days, stating what it has done to correct the violations and prevent recurrence, or explaining any delay and giving a completion schedule. FDA also recommends a qualified consultant to help meet current good manufacturing practice (CGMP) rules before resuming U.S. drug manufacturing.
Who should pay attention
- brands that buy OTC drugs or hand sanitizer from this contract manufacturer
- U.S. importers and distributors of hand sanitizer
- quality teams qualifying China-made OTC drug suppliers
This is a summary. Read the original letter on fda.gov.